Introduction
Usher syndrome type IIIA (USH3A), characterized by progressive hearing loss and retinitis pigmentosa, is caused by mutations in CLRN1 encoding clarin-1 (refs. 1, 2, and Figure 1A ). CLRN1 transcripts predict several isoforms (3) . At least 3 splice isoforms have been reported; reverse transcriptase PCR (RT-PCR) and Western blots on the inner ear and eye revealed the expression of isoforms 2 (containing exons 1, 3, and 4) and 3 (containing exons 1 and 4) ( Figure 1, A and B) . All the known CLRN1 mutations are located in the 3 exons of isoform 2 (1) (2) (3) (4) (5) . CLRN1 isoform 2 encodes a 232-amino acid tetraspan-like glycoprotein (1, 4, 6) . Studies of mutant mice lacking exon 1 of Clrn1 (7, 8) and knockdown approaches in zebrafish (9, 10) have revealed structural and functional defects of F-actin-enriched stereocilia in hair cells. Additional roles for clarin-1 have also been sought, as mouse Clrn1 transcripts have been detected in both hair cells and the auditory primary neurons, from embryonic day 16 (E16) to adult stages (1, 11) . Clarin-1 has also been detected at the apical and basal synaptic poles of hair cells and photoreceptor cells in the zebrafish (9, 12) . The prolonged peak and interpeak latencies of auditory evoked brainstem responses in Clrn1 -/-mice lacking exon 1 suggest a delayed activation of auditory primary neurons and transmission along the central auditory pathway (7) . The amino acid sequence of clarin-1 displays some similarity to that of the Ca 2+ channel subunit protein CACNG2 (stargazin) (1), a tetraspan protein involved in postsynaptic AMPA receptor trafficking and clustering in the postsynaptic active zone (13, 14) . Together, these data suggest a possible function of clarin-1 in hair cell synaptic transmission, a function that remains to be characterized.
We investigated the possible role of clarin-1 at hair cell ribbon synapses, by generating 2 new clarin-1-deficient mouse models ( Figure 1A ): one with an early ubiquitous deletion of Clrn1 exon 4 (Clrn1 ex4-/-mice) and the other with a hair cell-specific postnatal deletion of Clrn1 exon4 (Clrn1 ex4fl/fl Myo15-Cre +/-mice). The elimination of exon 4, which is common to all mouse clarin-1 isoforms (refs. 1-5; see also Figure 1B ), should lead to Clrn1-null mice. Synaptic defects were observed in both types of clarin-1-deficient mice. Through the combination of a comparative morphofunctional analysis of these mice and biochemical studies, we showed that clarin-1 was essential for the structural organization and function of the presynaptic Ca V 1.3 Ca 2+ channels at the inner hair cell
Clarin-1, a tetraspan-like membrane protein defective in Usher syndrome type IIIA (USH3A), is essential for hair bundle morphogenesis in auditory hair cells. We report a new synaptic role for clarin-1 in mouse auditory hair cells elucidated by characterization of Clrn1 total (Clrn1
ex4-/-
) and postnatal hair cell-specific conditional (Clrn1 ex4fl/fl Myo15-Cre
ex4-/-mice were profoundly deaf, whereas Clrn1 ex4fl/fl Myo15-Cre +/-mice displayed progressive increases in hearing thresholds, with, initially, normal otoacoustic emissions and hair bundle morphology. Inner hair cell (IHC) patch-clamp recordings for the 2 mutant mice revealed defective exocytosis and a disorganization of synaptic F-actin and Ca V 1.3 Ca 2+ channels, indicative of a synaptopathy. Postsynaptic defects were also observed, with an abnormally broad distribution of AMPA receptors associated with a loss of afferent dendrites and defective electrically evoked auditory brainstem responses. Protein-protein interaction assays revealed interactions between clarin-1 and the synaptic Ca V 1.3 Ca 2+ channel complex via the Ca V β 2 auxiliary subunit and the PDZ domain-containing protein harmonin (defective in Usher syndrome type IC). Cochlear gene therapy in vivo, through adeno-associated virus-mediated Clrn1 transfer into hair cells, prevented the synaptic defects and durably improved hearing in Clrn1 ex4fl/fl Myo15-Cre +/-mice. Our results identify clarin-1 as a key organizer of IHC ribbon synapses, and suggest new treatment possibilities for USH3A patients.
Clarin-1 gene transfer rescues auditory synaptopathy in model of Usher syndrome Myo15-Cre +/-mice (red), ABR thresholds (mean ± SD) progressively increase to reach severe deafness at P21-P28 as compared with those in control mice (grayblack (Figure 2 , B and E). In place of their normal V shape, the OHC hair bundles had a wavy, hooked form, and were occasionally fragmented into 2 or 3 clumps of stereocilia (Figure 2, A, B , D, and F, and Supplemental Figure 2 , A and B). On P12, the short row of stereocilia had almost entirely regressed in both the IHCs and the OHCs of Clrn1 ex4-/-mice ( Figure 2 , B and E, and Supplemental Figure 2B ). These abnormalities were observed throughout the cochlea, at its base, middle, and apex, consistent with the profound hearing loss in Clrn1 ex4-/-mice. By contrast, similar analyses in Clrn1 ex4fl/fl Myo15-Cre +/-mice showed that the IHC and OHC hair bundles were normal in shape until P30, with the typical 3 graded rows of stereocilia ( Figure 2 , A, C, D, and F, and Supplemental Figure 2C and Supplemental Figure  3A ). On P30, in both Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-mice, the coupling between OHCs and the overlying tectorial membrane was preserved, as indicated by the presence of imprints of the tallest row of stereocilia on the lower surface of the tectorial membrane and the normal distribution of stereocilin associated with these imprints ( Figure 2G and Figure 3 , A and B). However, in Clrn1 ex4fl/fl Myo15-Cre +/-mice, from P30 onward, the stereocilia of the short row were heterogeneous in length, with some missing entirely, in both the IHCs and the OHCs. The stereocilia progressively regressed until the hair bundles degenerated completely, as observed on P120 (Supplemental Figure 3, A and B) .
We explored the distribution of the USH proteins of the mechano-electrical transduction machinery (18) ex4-/-OHCs with fragmented hair bundles, the staining of the F-actin-labeled cuticular plate on the apical surface was heterogeneous, with furrows corresponding to regions of clumped stereocilia ( Figure  3C ). By contrast, F-actin staining was homogeneous in Clrn1 ex4fl/fl Myo15-Cre +/-mice, in which all the OHCs had normal V-shaped hair bundles and a normal cuticular plate, regardless of the stage or cochlear position analyzed ( Figure 3D ). Myo15-Cre +/-mice between the ages of P15 and P20. In response to loud sound stimuli (SPL of 95 dB), for which the cochlear response is independent of the amplifying activity of OHCs, CAP latencies (IHC) ribbon synapse and, subsequently, for the distribution of postsynaptic AMPA receptors. Finally, the virus-mediated transfer of the clarin cDNA into the cochlea durably prevented synaptic defects and hearing loss in Clrn1 ex4fl/fl Myo15-Cre +/-mice.
Results
Production of Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-knockout mice. RT-PCR showed that all 3 Clrn1 isoforms (1, 2, and 3) were present in the auditory hearing organ on postnatal day 15 (P15) and P30, whereas only isoforms 2 and 3 were found in isolated auditory hair cells ( Figure 1B) . We investigated clarin-1 function by generating 2 types of clarin-1-deficient mice. The first, a mouse model with a ubiquitous embryonic Clrn1 deletion, was obtained by crossing of Clrn1 ex4fl/fl mice, in which exon 4, the exon common to all clarin-1 isoforms, is floxed ( Figure 1A) Myo15-Cre +/-mice, from P15, just after hearing onset (P12-P13 in mice), until P60. In Clrn1 ex4-/-mice, ABR thresholds following tone bursts were markedly high over the entire 5-to 40-kHz frequency range, from P15 onward, at a sound pressure level (SPL) exceeding 90 dB, versus only 20-40 dB in control mice ( Figure 1, C and D) . In addition, distortion-product otoacoustic emissions (DPOAEs), which probe the activity of outer hair cells (OHCs), the mechanical amplifiers of the sound stimulus, were undetectable in these mice with a constitutive clarin-1 knockout ( Figure 1E ). By contrast, Clrn1 ex4fl/fl Myo15-Cre +/-mice displayed progressive hearing loss from P15 to P60 (Figure 1, C and D) . Interestingly, at P15-P20, the ABR thresholds of these mice were 20-40 dB higher than those of control mice, for all frequencies, whereas DPOAEs were similar to those in control mice ( Figure  1E and Supplemental Figure 1B ). Hearing thresholds continued to increase with aging, reaching an SPL of 75-100 dB by P30-P60, across the 5-to 40-kHz frequency spectrum ( Figure 1 , C and D). From P20 onward, DPOAE thresholds also progressively increased, to an SPL 20-30 dB above that of control mice on P44 ( Figure 1E) (Figure 4 , F and G). This negative shift began on P9 before the occurrence of significant changes in Ca 2+ current amplitude and density, and increased over subsequent days. A similar negative shift was also observed in Clrn1 ex4-/-mice on P9 and P13 (Supplemental Table 1 ). On P18, the steepness of the voltage-dependent activation curve was also significantly lower in the mutant mice (4.2 ± 0.1 pA/mV, n = 7 cells) than in control mice an immature stage before the onset of hearing, IHCs from both Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-mice had normal Ca 2+ currents, with amplitudes and densities similar to those of IHCs from control littermates (Figure 4 , A, C, and E, and Supplemental Table  1 ). From P13 to P18, after the onset of hearing, Ca 2+ current density gradually declined to steady-state levels below the values obtained on P6 in control mice, whereas a much less pronounced downregulation was observed in the IHCs of Clrn1 ex4-/-and Clrn1
ex4fl/fl
Myo15-Cre +/-mice ( Figure 4 , B, D, and E, and Supplemental Table  1 ). On P18, the Ca 2+ current density in Clrn1 ex4-/-and Clrn1
Myo15-Cre +/-mice was almost twice that in control mice. These (5.7 ± 0.2 pA/mV, n = 8 cells; P < 0.05; Supplemental Table 1 ). In addition, the kinetics of Ca 2+ current activation at negative membrane potentials were slower in both Clrn1 ex4-/-( Figure 4H ) and Myo15-Cre +/-) displayed similar sequential changes in the activity and expression of IHC Ca 2+ currents: a normal initial upregulation peaking on P9, followed by an abnormally weak downregulation of the density of these currents after P9. We then investigated Ca 2+ -triggered exocytosis in Clrn1 ex4-/-and Clrn1
Myo15-Cre +/-IHCs ( Figure 5 ). Analyses of the membrane capacitance changes (ΔC m ) of these IHCs in response to brief depolarizing voltage steps showed that the Ca 2+ efficiency and kinetics of exocytosis were normal at P9 ( Figure 5 , A and C), but decreased from P13 onward ( Figure 5 , B and D, and Supplemental Table  2 ). We then probed the intracellular Ca 2+ sensitivity of the exo- ous intracellular concentrations of the Ca 2+ chelator EGTA ( Figure  5H ). After hearing onset, the Ca 2+ channels and synaptic vesicles of normal mouse IHCs are spatially organized into a nanodomain configuration, which is thought to account for the lack of sensitivity of exocytosis to EGTA in these cells (24) . Accordingly, increasing the concentration of intracellular EGTA from 1 to 5 mM did not affect the kinetics of exocytosis evoked during brief pulses, from 10 to 100 milliseconds, in P18 control mice (τ = 25 ± 10 ms and 33 ± 18 ms, respectively, P = 0.5; Figure 5H ). This time is generally thought to correspond to the time required for the release of the readily releasable pool of vesicles in IHCs at room temperature (22°C-24°C) and with 5 mM extracellular Ca 2+ (24, 25) . By contrast, the incubation of 5 mM intracellular EGTA with P18 IHCs from Clrn1 ex4fl/fl Myo15-Cre +/-mice led to a further decrease in the mice) had a mature plate-like shape similar to that observed in control mice of the same age ( Figure 6 , E and F). Over subsequent days, the fraction of immature ribbons observed in Clrn1 ex4-/-IHCs decreased from 40% (n = 31) on P15 to less than 20% (n = 17) on P28, thereby reaching near-normal values ( Figure 6F ). The shapes of the synaptic ribbons in Clrn1 ex4fl/fl Myo15-Cre +/-IHCs were indistinguishable from those in control IHCs, on both P15 and P28. On P28, most of the ribbons (93 %, n = 42) had the plate-like shape typical of mature synapses ( Figure 6F) . Thus, the early constitutive deletion of clarin-1 in Clrn1 ex4-/-IHCs delayed the morphological maturation of the synaptic ribbons. Ca 2+ -mediated exocytosis was less efficient in the absence of clarin-1. We therefore characterized the coupling of Ca 2+ influx and exocytosis, by probing exocytosis following the application of vari- . By contrast to the untreated ears, the injection of AAV2/8-Clrn1 resulted in apparently normal hair bundles still visible on P120 (n = 3). However, despite the persistence of V-shaped bundles, the stereocilia in the short and middle rows are heterogeneous in length, and many of these stereocilia are missing. **P < 0.01, ***P < 0.001 (unpaired Student's t test).Scale bars: 1 μm. jci.org Volume 128 Number 8 August 2018
zones (23) . In control IHCs on P9, the submembranous F-actin cortical network was intensely stained and closely associated with the ribeye-and Ca V 1.3-coimmunoreactive spots ( Figure 7E ). By P13, this F-actin staining had extended further beneath the control IHC plasma membrane, forming dense intracellular cylindrical meshes of 0.5-1 μm in diameter (23) . Synaptic F-actin staining was associated with 1 or 2 ribeye-and Ca V 1.3-coimmunoreactive patches ( Figure 7F ). In P9 Clrn1 ex4-/-IHCs, despite the normal distribution of ribeye and Ca V 1.3, the continuous submembranous F-actin network appeared to be disrupted, as shown by the much weaker and fragmented pattern of F-actin staining ( Figure 7E ). On P13, synaptic F-actin staining in the IHCs of Clrn1 ex4-/-and Clrn1
Myo15-Cre +/-mice was even weaker, indicating a clear disorganization of the dense intracellular subcortical mesh network of F-actin ( Figure 7F , and data not shown).
The loss of clarin-1, therefore, led to disorganization of the synaptic F-actin network in IHCs, probably accounting for the abnormally large clusters of Ca V 1.3 Ca 2+ channels in the vicinity of the synaptic ribbons.
ribbons, in control mice; P < 0.05; Figure 7B ). Conversely, the mean size of the Ca V 1.3-immunoreactive patches was almost 40% larger in P13 Clrn1 ex4-/-mice (3.33 ± 0.17 μm 2 , n = 146 ribbons) than in P13 control mice (2.10 ± 0.10 μm 2 , n = 273 ribbons; P < 0.05; Figure 7B ). The proportion of the total area immunoreactive for both Ca V 1.3 and ribeye (an index of spatial proximity) in each active zone on P9 was not significantly different in , and control mice (80% ± 5%, n = 447 ribbons, in Clrn1 ex4-/-mice vs. 77% ± 2%, n = 347 ribbons, in controls; P = 0.5; Figure 7C ). By contrast, this proportion was lower in Clrn1 ex4-/-and Clrn1
Myo15-Cre +/-mice on P13 (40% ± 1%, n = 146 ribbons, in Clrn1 ex4-/-mice, and 48% ± 6%, n = 198, in Clrn1 ex4fl/fl Myo15-Cre +/ -mice, vs. 69% ± 8%, n = 273, in control mice; P < 0.05; Figure 7 , C and D). In P21 Clrn1 ex4fl/fl Myo15-Cre +/-mice, this proportion was 30% ± 6% (n = 205 ribbons) of that in control IHCs (n = 181 ribbons; P < 0.05). These results highlight a loose spatial coupling between Ca 2+ channels and the synaptic machinery in the absence of clarin-1.
The synaptic F-actin network is essential for the maintenance of a tight spatial organization of Ca V 1.3 Ca 2+ channels in IHC active of synaptic exocytosis ( Figure 10A) , and the clustering of Ca V 1.3 channels ( Figure 10B ) in the active zone of IHCs in P15-P18 Clrn1 ex4-/-mice injected with AAV2/8-Clrn1-IRES-GFP were identical to those of control IHCs (Supplemental Table 3 ). The ratio of the coimmunoreactive area (overlap between Ca V 1.3 and ribeye staining) to the Ca V 1.3-immunoreactive domain did not differ between control IHCs (64% ± 3%, n = 60 ribbons) and the IHCs of Clrn1 ex4-/-mice injected with AAV2/8-Clrn1-IRES-GFP (57% ± 3%, n = 54 ribbons; P = 0.22), whereas a significant difference was observed for the IHCs of untreated Clrn1 ex4-/-mice (38% ± 3%, n = 89 ribbons; P < 0.05). Thus, the re-expression of clarin-1 in the IHCs of clarin-1-deficient mice during the early postnatal period efficiently prevents the occurrence of synaptic defects caused by the absence of clarin-1.
Clarin-1 is a member of the L-type Ca 2+ channel complex. Based on the mispositioning of the Ca V 1.3 Ca 2+ channels in the absence of clarin-1, we investigated the molecular basis of the links between clarin-1 and components of the Ca V 1.3 Ca 2+ channel complex, such as the pore-forming subunit Ca V α 1 (aa 1-2,203, NP_058994.1) or the auxiliary subunit Ca V β 2 (aa 2-604, NP_4466303.1). We tested a possible direct interaction between clarin-1 and Ca V α 1 or Ca V β 2 in pull-down experiments using 2 overlapping glutathione-S-transferase-tagged (GST-tagged) clarin-1 fusion proteins: Clrn1-N (aa 1-136) contains the N-terminal region encompassing the first 2 transmembrane domains (TM1 and TM2), and Clrn1-C (aa 121-232) contains the C-terminal region encompassing TM3 and TM4 ( Figure 11A and Supplemental Figure 4A ). Following incubation with appropriate protein extracts from HEK293 cells (Figure 11 , A and B), a significant interaction was observed between GSTtagged Clrn1-N or Clrn1-C and cyan fluorescent protein-tagged (CFP-tagged) Ca V β 2 (n = 5, P < 0.05). No interaction was observed between the 2 clarin-1 fusion proteins and Ca V α 1 , CFP-tagged Rab11, or CFP alone, the last 2 of these proteins being unrelated and used as negative controls ( Figure 11, A and B) . Ca V α 1 has been shown to interact with Ca V β 2 (26). We therefore investigated the possible formation of a tripartite complex between Ca V α 1 , Ca V β 2 , and clarin-1. We used mCherry-tagged clarin-1, which was efficiently targeted to the plasma membrane in transfected HeLa cells (Supplemental Figure 4B) . We incubated FLAG-tagged Ca V AID (α interaction domain of Ca V α 1 ; aa 406-576, NP_058994.1), which is known to interact with Ca V β 2 , with protein extracts from transfected HEK293 cells producing mCherry-tagged clarin-1 alone or together with CFP-tagged Ca V β 2 ( Figure 11C ). An analysis of the proteins binding to the FLAG-tagged Ca V AID immobilized on anti-FLAG magnetic beads showed that significant immunoprecipitation of mCherry-tagged clarin-1 occurred only in the presence of CFP-tagged Ca V β 2 (n = 3, P < 0.05; Figure 11 , C and D). These findings indicate that clarin-1 and Ca V β 2 interact directly, facilitating the formation of a tripartite complex including Ca V α 1 .
We then investigated the possible involvement of other IHC synaptic proteins in the protein complex containing Ca V 1.3 channels and clarin-1. Clarin-1 contains a C-terminal class II PDZbinding motif (PBM type II). We therefore searched for a possible interaction of clarin-1 with the PDZ domain-containing protein harmonin, which is defective in Usher syndrome type IC and has also been shown to associate with Ca V 1.3 channels (27, 28) . Following incubation with protein extracts from transfected HEK293
Hearing rescue by virus-mediated gene transfer into the IHCs of clarin-1-deficient mice. Clrn1
-/-mice lacking exon 1 have no apparent IHC synaptic defects (8), whereas Ca 2+ -mediated exocytosis was found here to be less efficient in the IHCs of Clrn1 ex4-/-mice. We therefore investigated the possibility of these synaptic phenotypes being directly due to clarin-1 deficiency. We investigated whether the virus-mediated transfer of intact Clrn1 into the auditory hair cells could prevent synaptic defects and hearing decline in our 2 mouse models. We used a recombinant adeno-associated virus (AAV) carrying the mouse clarin-1 isoform 2 cDNA, encoding the predicted principal tetraspan glycoprotein of hair cells (Figure 1A) , followed by an IRES-GFP sequence for the visualization of transduced cells (AAV2/8-Clrn1-IRES-GFP) ( Figure 8A ). This viral vector was microinjected, through the round window membrane of the cochlea, into Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-mice on P1-P3 (Figures 8-10 ). Viral transduction was detected in 90% of IHCs and 20% of OHCs on P14-P20 ( Figure 8A ). We first checked, in control experiments, that injections of AAV2/8-Clrn1-IRES-GFP or AAV2/8-GFP into the inner ears of WT mice had no effect on hearing thresholds, and that the injection of AAV2/8-GFP into the inner ears of Clrn1 ex4fl/fl Myo15-Cre +/-mice failed to improve hearing sensitivity ( Figure 8B ).
In Clrn1 ex4-/-mice, hearing sensitivity in the AAV2/8-Clrn1-IRES-GFP-injected ear was poor, with ABR thresholds at 10 kHz and 20 kHz averaging 83 dB and 98 dB, respectively, whereas SPL values of 99 dB and 108 dB SPL, respectively, were obtained for the noninjected ears (P < 0.01 for each comparison; Figure 8C ). Structural analyses 3 weeks after the injection showed that the hair bundles of IHCs and OHCs in the injected ears of Clrn1 ex4-/-mice remained misshapen ( Figure 8D ). Interestingly, after similar injections of AAV2/8-Clrn1-IRES-GFP into the inner ears of Clrn1 ex4fl/fl Myo15-Cre +/-mice, audiometric tests on P22-P24 showed an almost complete rescue of hearing, at all frequencies tested ( Figure 9A ): the ABR thresholds in the microinjected ears at 10 kHz and 20 kHz averaged 20 dB and 38 dB, respectively (values similar to those obtained for control mice), as opposed to 67 dB and 80 dB for the noninjected ears (P < 0.001 for each comparison). Significant hearing conservation was still observed at P60, with thresholds averaging 60 dB and 67 dB SPL at low and high frequencies, respectively, whereas Clrn1 ex4fl/fl Myo15-Cre +/-mice that did not receive injections were profoundly deaf, with no measurable ABR waves at an SPL of 100 dB ( Figure 9 , B and C). Followup click ABR tests at P60 and P120 showed a progressive increase in hearing thresholds with aging in the AAV2/8-Clrn1-IRES-GFPtreated Clrn1 ex4fl/fl Myo15-Cre +/-mice (Supplemental Figure 3C ), probably reflecting a slow progressive degradation of DPOAEs after P20 (Figure 1E) , since viral transduction rates were low for OHCs (~20%; see Figure 8A ). Nevertheless, at P120, the hair cells of untreated Clrn1 ex4fl/fl Myo15-Cre +/-mice displayed profound hair bundle disorganization, whereas stereociliary structures were well preserved in ears into which AAV2/8-Clrn1-IRES-GFP had been injected ( Figure 9D and Supplemental Figure 3D ).
Despite the poor protection of hearing function in Clrn1 ex4-/-mice injected with AAV2/8-Clrn1-IRES-GFP, due to the early development of stereociliary abnormalities, ribbon synapse organization and function were well preserved in these mice. Indeed, Ca 2+ current characteristics, kinetics, the Ca 2+ efficiency jci.org Volume 128
Number 8 August 2018 , and Clrn1 ex4-/-mice. The first large downward inflection is due to an electrical artifact. In these stimulation conditions, wave I is not visible, as signal processing by the IHC synapse is bypassed. EEBR wave II (EII) and later waves (EIII and EIV), corresponding to the responses of higher auditory centers, are clearly visible in the control mouse (black trace, representative of 10 mice), absent in Figure 12B ). The distribution of postsynaptic GluA2/3 AMPA receptors at the distal end of the dendrites of primary auditory neurons was altered in the 2 types of clarin-1-deficient mice. In Clrn1 ex4fl/fl Myo15-Cre +/-mice on P24-P30, abnormally enlarged GluA2/3-immunoreactive territories were observed ( Figure 12C and Supplemental Figure 5 ). In control IHC ribbon synapses, the postsynaptic AMPA receptors normally formed small patches, less than 1 μm across, facing each ribbon and its cluster of Ca 2+ channels across the synapse (29, 30) . Transmission electron microscopy confirmed the expansion of the postsynaptic region and revealed an occasional loss of dendrite ends ( Figure 12, B and D) . Ultrastructural analyses of P28 Clrn1 ex4-/-mice revealed an abnormal swelling of IHC afferent terminals (n = 3 mice and 10 IHCs) and enlarged postsynaptic afferent terminals in Clrn1 ex4fl/fl Myo15-Cre +/-(representative of 3 mice and 10 IHCs) relative to control mice (n = 3 mice and 13 IHCs; Figure 12D ). The observed morphological defects resembled the postsynaptic afferent swelling observed during noise trauma or intracochlear perfusion with AMPA receptor agonists (31) . We investigated the loss of auditory neurons in the absence of clarin-1 further, by counting the parvalbumin-positive neurons cells producing the myc-tagged harmonin protein (aa 2-852, AAM44072.1), GST-tagged Clrn1-C bound to harmonin, whereas GST alone did not (n = 5, P < 0.05; Figure 11E) .
Thus, clarin-1 binds to the submembrane auxiliary subunit Ca V β 2 and the scaffold protein harmonin, 2 proteins of the Ca V 1.3 channel complex ( Figure 11F) .
The loss of clarin-1 in IHCs results in postsynaptic defects. Clrn1 is also expressed by the primary auditory neurons synapsing with IHCs (1, 7). We investigated the possible effect of an absence of clarin-1 on postsynaptic auditory nerve fibers, by recording electrically evoked brainstem responses (EEBRs) following direct stimulation of the primary auditory neurons. No significant EEBR waves were evoked in P20 Clrn1 ex4-/-mice (n = 6), indicating a strong electrical conduction defect in primary auditory neurons lacking clarin-1 ( Figure 12A ). On P20, in Clrn1 ex4fl/fl Myo15-Cre +/-mice, which lack clarin-1 only in the presynaptic hair cells, EEBR waves were, surprisingly, of smaller amplitude than those of control mice, and the peaks of waves II (EII) and III (EIII) were significantly delayed (n = 10; Figure 12A ). Clarin-1 expression in IHCs is, thus, also important for the maintenance of normal electrical conduction in primary auditory nerve fibers.
Immunofluorescence and ultrastructural analyses revealed the existence of various postsynaptic abnormalities in the absence of clarin-1. These synaptic abnormalities differed in ated neurons (33) . The virus-mediated postnatal delivery of a clarin-1 transcript to IHCs in the inner ear in vivo prevented the occurrence of synaptic defects in Clrn1 ex4-/-mice, demonstrating a direct causal link between clarin-1 deletion and IHC synaptic failure. By contrast, clarin-1 supplementation in Clrn1 ex4-/-mice did not correct the early developmental disorganization of the hair bundles, indicating that the synaptic function of clarin-1 is independent of its role in the hair bundle.
Clarin-1 is required for the tight clustering of presynaptic Ca V 1.3 channels. Our physiological, morphological, and molecular data indicate that, at time points close to hearing onset in mice, clarin-1 is critical for the establishment of tightly clustered Ca V 1.3 channels at the synaptic ribbon. We found that the absence of clarin-1 resulted in a marked disruption of the F-actin network at the IHC ribbon synapse similar to that observed at the apical surface of the cuticular plate and the stereocilia. Could the disruption of F-actin be responsible for the spatial disorganization of the Ca V 1.3 Ca 2+ channels? It has been suggested that a direct association between Ca V β 2 and F-actin promotes the directional transport of Ca 2+ channels to the plasma membrane of cardiomyocytes (34) , and, at the ribbon synapse of salamander photoreceptors, the confinement of Ca 2+ channels beneath the ribbon is regulated by actin and membrane cholesterol (35) . The disruption of F-actin with latrunculin-A in WT IHCs has been shown to disrupt the spatial distribution of Ca V 1.3 Ca 2+ channels (23) in a manner similar to that observed here, in the active zones of IHCs lacking clarin-1 from the 2 types of mutant mice.
Our biochemical analyses showed that clarin-1 could physically bind harmonin and Ca V β 2 , this channel subunit subsequently facilitating the formation of a tripartite complex including the pore-forming subunit of Ca V 1.3 Ca 2+ channels, Ca V α 1 . Consistent with these results, IHCs lacking harmonin in dfcr mice also have greater Ca 2+ currents, with a negative shift in voltage-dependence, and a clustering defect of Ca V 1.3 Ca 2+ channels (27, 28) . Based on the observed interactions of clarin-1 ( Figure 11E ), we suggest that clarin-1, harmonin, and Ca V 1.3 channels, via their Ca 2+ channel subunit Ca V β 2 , form a molecular platform associated with F-actin in the active zones of the IHC. By confining the Ca V 1.3 channels in the IHC active zone below the ribbon, this platform would produce overlapping Ca 2+ domains and synchronize the fusion of multiple synaptic vesicles in the active zone ( Figure 13 ).
An absence of clarin-1 also results in postsynaptic defects. Mirroring the expansion of the Ca V 1.3 channels in the IHC active zone, an abnormal distribution of postsynaptic AMPA glutamate receptors was also observed in the absence of clarin-1, along with structural changes, such as the fusion and/or swelling of afferent dendrites. Could the postsynaptic defects observed in Clrn1 ex4fl/fl Myo15-Cre +/-mice result purely from disorganization of the presynaptic Ca V 1.3 complex? This seems unlikely, because an absence of the presynaptic cytomatrix protein bassoon (36), Ca V β 2 (37), or harmonin (27, 28) in IHCs disorganizes the Ca V 1.3 channels without affecting the postsynaptic clustering of glutamate receptors. As an alternative hypothesis, clarin-1 may be a member of pre-and postsynaptic membrane focal adhesion complexes at the IHC ribbon synapse, possibly interacting with proteins known to be involved in the extracellular matrix at neuronal synapses, such as thrombospondins (38) , or in membrane-membrane synaptic adhesion, such as Eph/ephrins, cadherins, and the neurexin the Rosenthal's canals of control, Clrn1 ex4-/-, and Clrn1 ex4fl/fl Myo15-Cre +/-mice on P24-P30 ( Figure 12E ). Neuron density in the mid-base region decreased from 346.8 ± 16.7 neurons per 1,000 μm 2 (n = 4 cochleae from 3 mice) in controls to 259.6 ± 8.9 neurons per 1,000 μm 2 (n = 8 cochleae from 4 mice) in Clrn1 ex4-/-mice (P < 0.001, mean ± SD; ANOVA, post hoc Holm-Sidak test; Figure 12E ). No significant neuron loss was detected in Clrn1 ex4fl/fl Myo15-Cre +/-mice, which had 329.5 ± 10.7 neurons per 1,000 μm 2 (n = 6 cochleae from 3 mice; P > 0.05; Figure 12E ). Our results show that the postnatal hair cell-specific elimination of clarin-1, which causes a disorganization of the presynaptic Ca V 1.3 channel complex in the active zone of IHCs, also results in postsynaptic afferent nerve defects: (a) morphological changes in the afferent boutons, associated with a disorganization of the AMPA receptors; and (b) defective electrical conduction in the primary auditory neurons, probably partly due to a loss of afferent nerve fibers.
Discussion
Clarin-1, a tetraspan protein defective in Usher syndrome type IIIA (deaf-blindness), has been reported to be involved in hair bundle morphogenesis (7, 8, 32) . We show here that a deletion of clarin-1 leads to a lower Ca 2+ efficiency of exocytosis in IHCs, probably due to abnormal clustering of Ca 2+ channels in the active zones of the ribbon. We suggest that the binding of clarin-1 to the Ca V β 2 auxiliary subunit and the PDZ domain-containing protein harmonin couples the Ca V 1.3 Ca 2+ channel complex to the IHC exocytotic machinery. Virus-mediated Clrn1 transfer to mutant hair cells reversed the synaptic defects and restored hearing. These results reveal a new key role for clarin-1 at the IHC ribbon synapse, but they also raise important questions about the rehabilitation of hearing in USH3A patients.
Clarin-1 as a key component of the hair bundle and ribbon synapse of auditory hair cells. The presence of hair bundle abnormalities at birth in Clrn1 ex4-/-mice, and from P30 onward in Clrn1 ex4fl/fl Myo15-Cre +/-mice, clearly indicates that clarin-1 is essential for both the development and maintenance of normal auditory hair bundle structure and function. These findings are consistent with previous reports on Clrn1 -/-total knockout mice obtained by deletion of Clrn1 exon 1 (7, 8) . Our detailed analysis of both Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-mice also highlighted an additional essential role of clarin-1 at the auditory IHC ribbon synapses in the spatial organization and regulation of Ca V 1.3 Ca 2+ channels ( Figure 13 ). Synaptic abnormalities appeared only after P9, close to the time of hearing onset at P12, in both Clrn1 ex4-/-and Clrn1 ex4fl/fl Myo15-Cre +/-IHCs, indicating a requirement of clarin-1 for IHC synapse maturation and/ or maintenance, but not for IHC synapse formation. A recent study of Clrn1 -/-mutants in the A/J mouse genetic background showed that these mice had impaired vision, probably due to the unique function of clarin-1 in synaptic transmission between the light-sensitive photoreceptor cells and their associated neurons (33) . Electroretinogram measurements in these mice revealed a normal A wave response (indicative of a normal phototransduction machinery), with a significantly smaller B wave than observed in WT mice, consistent with lower levels of synaptic transmission between rod photoreceptor cells and their associ-jci. (46) , confirm that gene therapy approaches should treat genetic inner ear disorders very effectively. Future studies targeting both hair cells and neurons in clarin-1-deficient mice are, however, required, to obtain insight into how best to preserve cochlear neurons over time in the absence of clarin-1, which would be of great benefit in USH3A patients fitted with cochlear implants.
Methods
Generation of clarin-1-deficient mice. To engineer clarin-1-deficient mice, we used the Cre-lox system to delete Clrn1 exon 4 ( Figure 1, B microdissected separately and quickly frozen in liquid nitrogen and stored at -80°C until processing. Total RNA (100 ng) was reverse-transcribed with the SuperScript III One-Step RT-PCR system (Invitrogen) as described by the manufacturer using various isoform-specific primers (see Supplemental Methods). For expression vectors, antibodies, protein-protein interactions (47), immunofluorescence (48) , and electron microscopy analyses (49) , see Supplemental Methods.
In vivo auditory tests. Auditory brainstem responses (ABRs), compound action potentials (CAPs), and distortion-product otoacoustic emissions (DPOAEs) were recorded in anesthetized mice, and the results were analyzed as previously described (50) (also see Supplemental Methods).
Hair cell electrophysiology. All IHC recordings were performed in the 20%-40% normalized distance from the apex, an area coding for frequencies ranging from 8 to 16 kHz. For IHC electrophysiological recordings, mouse organs of Corti, at different stages of postnatal development, were bathed at room temperature (22°C-24°C) in an extracellular solution, with the following composition: 135 mM NaCl, 5.8 mM KCl, 5 mM CaCl 2 , 0.9 mM MgCl 2 , 0.7 mM NaH 2 PO 4 , 5.6 mM glucose, 2 mM Na-pyruvate, 10 mM HEPES, 250 nM apamin, 0.5 μM XE-991, pH 7.4. Ca 2+ currents and membrane capacitance were recorded in the whole-cell voltage-clamp configuration, using 3-to 5-MΩ-resistance pipettes with an EPC 10 amplifier and Patchmaster software (HEKA Elektronik) as previously described (19, 23) . Gene transfer through the cochlear round window membrane. A recombinant adeno-associated virus (AAV) carrying the mouse Clrn1 followed by an IRES-GFP sequence (AAV2/8-Clrn1-IRES-GFP) was microinjected through the round window membrane on anesthetized P1-P3 mice. The virus was packaged and titrated by Penn Mediin/neuroligin proteins (39) . Defects of the presynaptic scaffold protein Syd1 (synaptic-defective-1) at the neuromuscular junction result in abnormal presynaptic neurexin targeting, impairing the postsynaptic density cluster organization of neuroligin-1 and glutamatergic receptors (40) . A role for the auxiliary Ca 2+ channel subunit Ca V α 2 δ 2 in the trans-synaptic coupling of IHC Ca V 1.3 channels with the postsynaptic AMPA receptor complex has also been recently proposed (41) . Based on our findings in clarin-1-deficient mice, we suggest that clarin-1 is a member of the transsynaptic membrane interaction adhesion complex at the IHC ribbon synapse, a complex essential for the focal alignment of the presynaptic Ca V 1.3 channels and release sites with the postsynaptic AMPA receptors ( Figure 13B) .
Impact on the clinical exploration and treatment of USH3. In humans, despite a number of disabling CLRN1 mutations identified in USH3A patients, audiometric tests, essentially ABR measurements, indicate that the hair cells differentiate and function normally for long periods of time (42, 43) . Indeed, almost all USH3A patients develop normal speech, and, although an elevation of hearing thresholds is diagnosed in most patients before the age of 10 years, some patients display only mild to moderate hearing threshold elevation at the time of detection, at an age of 30-40 years (42, 43) . The discrepancy in hair cell phenotype between humans (42, 43) and Clrn1 total knockout mice (7, 11) suggests that compensatory mechanisms, possibly involving genes encoding other members of the clarin family (CLRN2 and CLRN3), operate much more efficiently, particularly during embryogenesis and early postnatal development, in humans than in mice. USH1 and USH2 patients present congenital hearing loss. By contrast, there is a therapeutic window in USH3 patients during which potential therapeutic strategies for preventing or halting hearing decline can be tested. In Clrn1 ex4fl/fl Myo15-Cre +/-mice, hearing impairment was also progressive, starting as early as P15 and reaching profound deafness at P60. These features closely match the progressiveness of hearing loss in USH3A patients. Progressive hearing loss has also been reported for Clrn1 -/-total knockout mice in which clarin-1 was transiently expressed in the hair cells, under the control of the Atoh1 promoter, between E12.5 and P3; these mice were referred to as KO-TgAC1 mice (32) . Interestingly, a single cochlear injection of AAV2/8-Clrn1 (isoform 2) into KO-TgAC1 mice or our conditional Clrn1 ex4fl/fl Myo15-Cre +/-mice durably preserved the hair cells and hearing.
Cochlear implants are currently the only medical option available for treating severe to profound deafness in USH3A patients. These prosthetic devices consist of electrode arrays that bypass the hair cells and stimulate the primary auditory neurons directly. However, very little is known about the long-term performance of cochlear implants, as the number of spiral ganglion neurons progressively declines with aging in these patients. The significant decrease in the number of spiral ganglion neurons in Clrn1 ex4-/-mice and the delayed EEBR waves observed here in Clrn1 ex4fl/fl Myo15-Cre +/-mice, if replicated in USH3A patients, would result in a poor long-term efficacy of cochlear implants. Considerable variability and poor performances have indeed been reported for cochlear implants in USH3A patients (ref. 44 and Claes Moller, Örebro University, personal communication), but there are currently no detailed and long-term follow-up
